Why the IOOF share price jumped on the Royal Commission report

IOOF Limited (ASX:IFL) still faces a long list of regulatory problems.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The IOOF Limited (ASX: IFL) share price jumped 8% in trade today to $5.27 thanks to investors bidding the financial planner and wealth manager higher on the back of the final report from the Hayne Royal Commission.

A lot of market commentators feared that IOOF's hybrid financial services business model would be a target for root and branch reform as a result of the Royal Commission, although it didn't turn out that way.

The Royal Commission didn't recommend banning what's known in the industry as "vertical integration" where financial planners sell their own employer's products in what could be a perceived conflict of interest.

The lack of specific criticisms of IOOF is also a positive for the financial planner as it aims to get its $1 billion deal to acquire Australia & New Zealand Banking Group's (ASX: ANZ) OnePath financial planning business over the line, including the required trustee approval from OnePath subsidiaries.

Despite today's share price bounce the IOOF share price is still down nearly 50% over the past year after the prudential regulator APRA moved to have its CEO, COO, and two directors barred from working on APRA regulated superannuation entities.

Therefore IOOF is a long way from being out of the regulatory woods yet.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

3 reasons this ASX 300 tech stock is forecast to leap 83% in 2026

A leading broker expects some outsized returns from this ASX 300 tech share. Let’s see why.

Read more »

gold share price represented by speeding golden bullet
Broker Notes

Why this surging ASX All Ords gold stock is tipped to rocket another 233%

A leading broker expects outsized gains from this ASX All Ords gold stock. But not without risk.

Read more »

Engineer at an underground mine and talking to a miner.
Opinions

Best ASX mining stock to buy right now: Fortescue or South32?

Here’s my pick between the two mining majors.

Read more »

A blockchain investor sits at his desk with a laptop computer open and a phone checking information from a booklet in a home office setting.
Broker Notes

3 buy-rated ASX 300 shares at 52-week lows

They've fallen far over the past 12 months but have buy ratings from the experts.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Broker Notes

Bell Potter names more of the best ASX 200 shares to buy in December

These are best buys according to the broker. Here's what it is saying about them.

Read more »

Man with his head on his head with a red declining arrow and A worried man holds his head and look at his computer as the Megaport share price crashes today
Share Fallers

Why is the Bapcor share price crashing 19% on Tuesday?

Investors are punishing Bapcor shares today. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »